product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Influenza A Matrix Protein
catalog :
MCA401
quantity :
1 mg
price :
660 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
GA2B
reactivity :
Alphainfluenzavirus, Influenza A virus (A/Puerto Rico/8/1934(H1N1))
application :
western blot, immunocytochemistry
more info or order :
citations: 16
Published Application/Species/Sample/DilutionReference
  • western blot; Alphainfluenzavirus; loading ...; fig 4b
Kühnl A, Musiol A, Heitzig N, Johnson D, Ehrhardt C, Grewal T, et al. Late Endosomal/Lysosomal Cholesterol Accumulation Is a Host Cell-Protective Mechanism Inhibiting Endosomal Escape of Influenza A Virus. MBio. 2018;9: pubmed publisher
  • western blot; Alphainfluenzavirus; loading ...; fig 4c
Chen S, Jeng K, Lai M. Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs. J Virol. 2017;91: pubmed publisher
  • western blot; Alphainfluenzavirus; fig 6a
Londrigan S, Short K, Ma J, Gillespie L, Rockman S, Brooks A, et al. Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle. J Virol. 2015;89:12319-29 pubmed publisher
  • western blot; Alphainfluenzavirus
Su W, Hsu S, Lee Y, Jeng K, Lai M. A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription. J Virol. 2015;89:11245-55 pubmed publisher
  • western blot; Alphainfluenzavirus
Hsu S, Su W, Jeng K, Lai M. A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication. J Virol. 2015;89:3671-82 pubmed publisher
  • western blot; Alphainfluenzavirus; 1:1000; fig 2
Liedmann S, Hrincius E, Guy C, Anhlan D, Dierkes R, Carter R, et al. Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in influenza virions. Nat Commun. 2014;5:5645 pubmed publisher
Lesch M, Luckner M, Meyer M, Weege F, Gravenstein I, Raftery M, et al. RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals. PLoS Pathog. 2019;15:e1007601 pubmed publisher
Kupke S, Riedel D, Frensing T, Zmora P, Reichl U. A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome. J Virol. 2019;93: pubmed publisher
Mazel Sanchez B, Boal Carvalho I, Silva F, Dijkman R, Schmolke M. H5N1 Influenza A Virus PB1-F2 Relieves HAX-1-Mediated Restriction of Avian Virus Polymerase PA in Human Lung Cells. J Virol. 2018;92: pubmed publisher
Su W, Yu W, Huang S, Lai M. Ubiquitination of the Cytoplasmic Domain of Influenza A Virus M2 Protein Is Crucial for Production of Infectious Virus Particles. J Virol. 2018;92: pubmed publisher
He J, Sun E, Bujny M, Kim D, Davidson M, Zhuang X. Dual function of CD81 in influenza virus uncoating and budding. PLoS Pathog. 2013;9:e1003701 pubmed publisher
Kirkeby S, Martel C, Aasted B, Vorum H. Carbohydrate determinants in ferret conjunctiva are affected by infection with influenza H1N1 virus. Curr Eye Res. 2013;38:1027-35 pubmed publisher
Moncorgé O, Long J, Cauldwell A, Zhou H, Lycett S, Barclay W. Investigation of influenza virus polymerase activity in pig cells. J Virol. 2013;87:384-94 pubmed publisher
Demirov D, Gabriel G, Schneider C, Hohenberg H, Ludwig S. Interaction of influenza A virus matrix protein with RACK1 is required for virus release. Cell Microbiol. 2012;14:774-89 pubmed publisher
Kirkeby S, Martel C, Aasted B. Infection with human H1N1 influenza virus affects the expression of sialic acids of metaplastic mucous cells in the ferret airways. Virus Res. 2009;144:225-32 pubmed publisher
Jimenez G, Planchon R, Wei Q, Rusalov D, Geall A, Enas J, et al. Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge. Hum Vaccin. 2007;3:157-64 pubmed
image
image 1 :
Bio-Rad MCA401 image 1
Published customer image: . Mouse anti Influenza A Matrix Protein antibody, clone GA2B used for the evaluation of influenza matrix protein expression in infected cell lysates by western blotting. Image caption: . Tyrosine kinase activity is required for efficient uptake of IAV. (A, B, C) A549 cells were treated with genistein (50 uM, [+]) or (D, E) a mixture of several RTK inhibitors (each 10 uM, [+] see experimental procedures) or the solvent control (DMSO,[−]) respectively for 60 min at 37°C or over night prior to infection. (A) Upon genistein treatment, cells were either mock infected or infected with influenza virus A/FPV/Bratislava/79 (H7N7) (FPV; MOI = 100) for further 30 min. Virus particles were visualized in immunofluorescence (IF) microscopy, via a hemagglutinin (HA)-specific rabbit antiserum and an Alexa 594-conjugated chicken anti-rabbit IgG. The nuclei were stained with DAPI. The white arrowheads point to virus particles lining at the cell border. (B, D) After infection with influenza virus A/Puerto-Rico/8/34 (H1N1) PR8 (MOI = 8) for further 30 min, an acidic wash (PBS, pH 1.3, 4°C) was performed before cell-lysis. Internalized virus particles were visualized with a M1 monoclonal antibody in Western-blot (WB) analysis. Equal protein load was verified by ERK2 detection. The relative amount of M1 was quantified (B and D lower panels). Relative M1 densities are expressed as mean ±SD of three independent experiments. (C, E) Cells were infected with FPV or PR8 (MOI = 4) for 8 h; upon the virus-attachment period an acidic wash (PBS-HCl, pH 5.5) was included. Progeny virus titers were determined by standard plaque assays. Data represent mean values of at least three independent experiments ±SD. Statistical significance was assessed by student s t-test (*) p PLoS Pathog 6(9): e1001099 .
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA401
Description :
Mouse anti Influenza A Matrix Protein
Specificity :
Influenza A Matrix Protein
TargetSpecies :
Viral
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB,P,IF
ApplicationTypes :
Western Blotting,Immunohistology - Paraffin,Immunofluorescence
Clone :
GA2B
Quantity :
1 mg
Quantity Value :
1
Quantity Type :
mg
GO Accessions :
GO:0005886,GO:0003723,GO:0005829,GO:0005198,GO:0005654,GO:0019064,GO:0019061,GO:0019065,GO:0019070,GO:0019072,GO:0019076,GO:0019083,GO:0030666,GO:0030683,GO:0031904,GO:0042025,GO:0046796,GO:0055036,GO:0016020
GOTerms :
plasma membrane,RNA binding,cytosol,structural molecule activity,nucleoplasm,viral envelope fusion with host membrane,uncoating of virus,receptor-mediated endocytosis of virus by host,viral genome maturation,viral genome packaging,release of virus from host,viral transcription,endocytic vesicle membrane,evasion by virus of host immune response,endosome lumen,host cell nucleus,viral genome transport in host cell,virion membrane,membrane
Uniprot Accessions :
P03485,P03487
Gene :
M1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=956527
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
471
PriceEUR :
660
PriceUSD :
660 USD
PriceCHF :
718
PriceSEK :
7194
PriceNOK :
7230
PriceDKK :
4921
NotForSaleInCountries :
AU
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.